INDS ASVINI

DEPARTMENT OF RADIO-DIAGNOSIS &a IMAGING

Colaba, Mumbai - 4 00 005. Tel. 221 4 3705

X-RAY/ ANGIOGRAPHY/ CT/ MRI / MAMMOGRAPHY

I.D. No.: :ff ,~r, d

YRS

C/0 : _ __ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

P.No.: ~ C ½IT7 5 .RANK: _ ~_~r_ _ _ _ NAME : _ _ _ _ _ _ _ _ __

SHIP/ UNIT ::_ 1,:;

22~4~U:___ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

Encl : Film I Report I C.D. "--1 eI }\-/1, 1)orn(,., . 'ff'

 INHS ASVINI
DEPARTMENT OF RADIO-DIAGNOSIS & IMAGING
Colaba, Mumbai - 400 005 . Tel . 2214 3705

X-RAY/ ANGIOGRAPHY/ CT / MRI / MAMMOGRAPHY

I.D. No.: # ?z'J0/ 2--J

J

PATIENT'S NAME : _ _--:.:l?~K.:a......--Jc~1.L..!.M.Ll.---------AGE: '2.2--

C/O : _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

NAME: _ _ _ _ _ _ _ _ _ __
P. No.: '1°YI r:}9 3 RANK: ~Cir
SHIP/ UNIT : _ _ _..:.~::.?~ffU:_::__ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

/#-Cl (_j/E'ST
Encl: Film/ Report/ C.D.
 --
--------===---
F..a...on _ _
lob tnve1t!gaUo~ Report

• oradr • 11 ~ 1 ~!}So,_.,_....,_-=- r~ I -
~~~~--------------
I
-·. . . . ------= -----------"""--------
I
l
r
KAEMOTOlOGY

nt -:f
~~- B.t _ BIOCHEMJSTP.Y

I N , .,... ,; RR
r. " :e:1 ~cl'1 n::,...c.:_
I ~~_M_______ ..;;;,,,..---"--------~---ez:
__~_______c:g.;..:::::..~--.:..--·_7•_:..-4....,__;..
I l~..,µ!i ,. i!C _ ___:.;fZD-
Aud~_ _ _ _ _ _q#J..:::::.. __.,_i:..:.;..,
1ii f<t"lJ UPU> PftOf 1£
ESS
I A.EC
I

I ~

STOOL
On/Cyst

SEROlOGT
=~~'~----~
....:~::::::~:;e=-----------+i---:--.. . . . . ------====lolll:=..
~~~ ~~~ 'i==---===-=
t.,-
~
r

I
 /lj/07v:-
-#
L,.
~ n:
.
SerNo \
Lab /11;vest/gation Report
Rank.
, Name:
.
.
,
,J
I
I

. ~.
,ff'ade: Age/Sex. Unit: Mob No; .
~
J J
~ .. '
. ..
Clinical Notes/Diagnosis , · Date:
.. ,·

~$
~
, . HAEMOTOLOGY
. Normal Range . BIOCHEMISTRY · · '
I ,
,
.
, .
,
Normal Ran ~e

-Hb
TLC
II• V.
l/2,fJL'
_g/dl
/cmm
(M~13-l 7,F:11.S-14.S) Sugar(F)
(4000-11000)
I

Sugar(PP) .
,..... . I
mg/di
mg/di .
'
I
(60-110)
(<140)
DLC '
Sugar(R) ' mg/dl . (<140)
. RFT
Neutrophils .v/Y. % (40-75) I
~
.
< •
.
Eosinophil . 0 t/ . % (01-06) Urea . mg/di .~ (20-40)
Monocyte ·Dt: % (01-08) Creatinlne . . mg/di · (0.7-1.4)

. Lymphocytes l/2- ¾ . (20-45) Uric Acid ,. . . .. mg/di· (2.0-7.0)

cu
~

Basophils % (<01)
LIPID PROFILE
ESR mm in lhour (M:<10,F:<20) Total CholesteroJ mg/di (<200)
AEC (<450) Triglyceride mg/di (<?,60)
Platelets / •.2~ -. (1.5-4.SLac) HDL . mg/di (40-60)
I'-,.
' LDL
MP
.
- .. mg/dt
- 'mg/di
(<100)
- -VLDL (<35)
.. '
URINE .' LFT ;

Appearance Bilir~bin- (T) mg/dl · (0.1-1.0)

.
Sp. Gravity
. .. (C) - tng/dl (O..l.-0.4)
. Protein
Sugar
. ,

.
.
SGOT
. . (UC) . mg/dl
·- IU/L
( 0.2-0.7)
(<40)
'
ME - SGPT iU/L. .. (<40)
STOOL
.
. ,

Appearance Ova/Cyst , -. Ht ~

Blood/mucous ME Wt .
. . SEROlOGY . ~
BMI
...
I

Dengue HIV µ...,.,..>_ . '

I WIDAL
~

HbsAg . ~;(!_ \
.
l RA Factor
!CRP
f. ---
.

.
HCV
VDRL
-- -
'
,.

-,
"'""~-
·<Lll.J-
I ABO&Rh Grouping · . .... -
Gravlnde><

.. . ,.. .
. Officer 1/C Lab
1/C Lab
'

' •

.J
"" j . t4-a 1-\r

•
Operat.or
1 '
ID.•
f

, •
D~te' 2020/01 / 2.<-J
T ~e * 02:0:3
Mode VJB

VJBC l~L* 6 • 9 103/ ~L

RBC 3. 64 106 /UL
HGB 10.7 g/dt
HCT 30. 5 tt,
MCV - 8~3 •.q
fl
MCH 29. 4
r>g
MCf-iC 35.1g/dl
PLT AG)( 9 C-1 · 1Q3/ UL

L.YM% l1ll')i( 29. 0 ,;

MXD% l1JL~ 9 - 8 %
NEUT% l1JL>t- 6 1 • 2 ~
LYM# l'JL* 2 • 0 .-: 101/ .UL
MXD# l';L* 0. 7 x1031uL
NEUT# 1,JL)f(, 4 - 2 X 103/ UL

RDIIJ-SD 46. 9 fL
RDVJ--CV 15. 4 X
PDt" 1 1 • 9 rl
MP\(
p
 MH BHUJ LAB REPORTS
HAEMATOLOGY BIOCHEMISTRY Wida!
SUGAR (F) .................... (" ... mg/dL
ESR .................... Cinm fall 1st wintrobe's
SUGAR (PP) ......... ... ';J ...... mg/dL
Hb ........... u.~.~···· ·
gm/dl
1
SUGAR (R) ......n ..lJ..~······· mg/dL
TO .................... TH .................... .

J..
TLC .. i.JQ.Q .... cell/cumm UREA ............... k:1 ............ mg/dL AH .................... BH .....................
CREATININE .....0 .~.~ ... mg/dL
DLC BILIRUBIN ..... rly.. .. 7
~ tL .. mg/dL
POLY .~9... % LYMPH ...l.A ... % SGOT ........ q,_;rr................ IU/L
Dengue

MONO 0..~. % EOSINO ... 0.lj...% SGPT ........... 3.1.................. IU/L

Platelets ......... ....f..:/:Q... X..~.~ell/cumn? •
SEROLOGY (By Rapid method) ~
HbsAg ...............-BctcctedfNot Detected
NslAg. Positive/ Negative
CHOLESTEROL ................. mg/dL
TRIGLYCERIDE ................. mg/dL
IIDL ..................................... mg/dL
IgG Positive/ Negative
LDL ...................................... mg/dL
URIC ACID ......................... mg/dL IgG Positive / Negative

HCV .................. Detected/Not Det~

VDRL ................ R:eacror/Non Reactor
~ 3. ~ ~,-- i.\ IO(L-
Clinical pathology
Appreance ............................ . s . '~ ~ ·_,-- trf tV\L- .
Specific gravity .................... .
Reaction ............................... .
__..
.,,
'11bul!Jin
,,_ .............................. ..
Sugar .................................... .
PT1 ,
C'O<)-r-~
\

....- ,,.,.okcopic ......................... .

Ott
Besr.,it~t lob
~4 b . , I ,t•tr~
0 :ftp ft
 \ vlYf IC2LUI C: UI 'rne IVIU/
■ ■ ■ ■ ■ ■ ■

.~ :c..~ .
• ■ ■ a I ■
•■ a ~ a ■ e a I • a I a I e I I I I • ■ I I a a I • ■ I a I • a I e I I I I I
• • I I I • • I e I e • a •

1I !C ~
, '{ PART - '!fV •c,iwmow-:.i,11cnn
-~ MH J P. HIV.f/HIV_,,
. Li.:rs:nal particulars:- -4( ~
~
0 r.::'-.. I~
~ o _ _ _ _ _ Rank cJ CJL1 Name .u · \Sl- L)~9\. Unit -f--:::

Result of HIV test

\ 111~
Elisa/Rapid/simple ~"spita\ lab f.

., , ~ . , 11 ; tl<utrll
 Sample Profile
STP pHo..< Ultra
' Printed 'J9/01 /2020 02 26 20 PM
Analyzed . 29/01/2020 02 24·11 PM
Analyzer ID z1 ·1A16340N
D· I < ~ .
B r 752 6 mmHg
Sample Type Venous
Operator 123456
Releaser auto
Patient ID 1cu
Patient Name

Qther F@g~

Comments

Test Value Units Flags

pH 7 393
pC02 32 8 mmHg
p02 32.1 mmHg
S02% 58.2
Hct 34 %
Hb 11 0 g/dl
Na+ 138.6 mmol/L
K+ 3.56 mmol/L
Cl- 111 0 mmol/L
Ca++ 1.20 mmol/L
Mg++ 0.48 mmol/L
Glu mg/dl PC
Lac 2 2 mmol/L
TCO2 21 2 mmol/L
nCa
1 19 mmol/L
nMg
0 47 mmol/L
Gap 7 4 mmol/L
Ca++/Mg++ 2 5 mol/mol
BE-ecf -5 O mmol/L
BE-b -3 4 mmol/L
SBC 20 9 mmol/L
HCO3- 20 2 mmol/L
P50 28 5 rnmHg
O2Cap 15 3 mL/dL
O2Ct 9 0 mL/cJL
A 108 2 mmHg
 KUTCH
RADIOLOGY & IMAGING CENTRE
(A D,v,sion of KRIC Radio Diagnostic Pvt ltd I
• Email : kric2008@gmail.com • Website : www.kric.in
Kripalsinh Jadeja
, D.M .R.E. Dr. Bhaven Shah
sultant Rad iologist
M.D.
Consultant Radiologist ·•
Patient Name D K JAHA
MR No : D539
Modality : US
Gender : M
Age : 32Y
Date :29/01 / 2020
Referred By : DR RS RAWAT SIR

USG : ABDOMEN & PELVIS

LIVER : shows small size right lobe of liver with alteration of liver parenchymal echotexture w ith
irregular crenate d liver surface noted . Mild periportal echogenicity note d.
No ev idence of d ilated I HBR.CBD appear normal in calibre .
GALL BLADDER: show moderate diffuse thickening of wall.(Wall thi ck ness of 4 . 7 mm).
PANCREAS : appears normal in size and echotexture. No focal mass lesion or cha nges of
pa ncrea t i t is seen .
SPLEEN : appears moderate enlarged in size me~suring 18.6 cm along long axis and show normal
echotexture . No evidence of focal or diffuse lesion.
BOTH KIDNEYS : appear normal in size and echotexture with preservation of corticomedul\ ary
d iffe rentiation . No evidence of calculus, hydronephrosis or mass lesion involving either k idney .
RK : 11. 8x4. 9 cm LK : 11.9 x 4 . 5 cm
URINARY BLADDER : appears normal. No intrinsic lesion seen.
PROSTATE: Appears normal in size. Size: 2.9 x 4.6 x 3.6 cm, Volume: 25 .8 gm.
No e/ o paraaortic lymphadenopathy seen. Moderate ascites noted.
Mild omental thickening seen on right side perihepatic space.
CONCLUSION:
* Small size Right lobe at liyer with alteration of liver parenchymal echotexture with
irregular and crenated liver surface noted with Moderate diffuse thickening of wall of
Gall bladder with Moderate splenomegaly noted. Moderate ascites noted. Mild omental
thickening seen on right side perihepatic space.Mild periportal echogenicity noted .
P/o Changes of Liver parenchymal disease: cirrhotic liver disease likely.

ADV: Clinical co rrela t io n and furth er investigation.Thanks for ref ...

Dr. KRIPALSINH JADEJA

M.B,D.M.R.E
RADIOLOGIST
;I
11
I

,:
'

I
t
I
'
I
'
I ~
 - -==..-;: ..
Investigotion View Pag.c 1 of 2

•UHID ASVl.0000340151 Name DK JHA Gender MALE Age 32 Year(s)

Te!it Results between 31-0ct-1019 and 31-Jan-2020
,
Test Name Component Name 31-Jan-20 20

Albumin Albumin SerPl-mCnc 2.3

Proi!JrQ!!Jbln Tlmf: INR 1.28

frQthrornbin Tim!: PT Test 18.0

PrQthrQmbtn Time PT Control 13.8

~Y9'1[ Bani;12m Glucose Bld- mCnc 89

Qcngur; DENV IgM Ser QI NEGATIVE

~ DENV IgG Ser QI NEGATIVE

Dengue Dengue NSl NEGATIVE#31

~ Urea 12

Creatlnlnf: Creatinlne 0.77

~•liru!;!ln TQlal Biltrubln Total 3.6

SGOT SGOT 47
S,fil! SGPT 33

/\l~i}llng PhQSQhata~e Alkaline phosphatase 62

~Qdlum Sodium (Serum) 138
rotn~~1um Potassium (Serum) 3.9
Hncrnoglobin Hb 10.3

fOI EJ I I eus;gs;yt~ ~ounl WBC 4.3

Dlfff rentlnl LCU!,;0!,;Yl!;l !:;Qunt Lymphocytes # 1.2

DHfrrenLl,11 Ll;11cQs;Y!l! ~ount Monocytes # 0.4

D~lrfll 1<:11 I t•ucocytc C_Q.unt Neutrophlts # 2.6

[)1frercntl,ll (.!•ucgcy_ll> r_Q_l!!}1 Eoslnophlls # 0.1

Dlfle, !:!]lii11 Leu,ocyle ro_unt Basophlls # 0.0

D1ffer<>nt ,al LeucocyL~ ~ount Lymphocytes 27.2

D ifferential Leucocyte Count Monocytes 9.8

Differentia l Leucocyte ~ount Neutrophlls 59 .6

Differential Leucocyte Count Eoslnophlls 2.9

Differentia l Leu cocyte Count Basophlls 0.5

105
Platelet Count
Platelet
Rem arks

PCV 29 .9
Packed Cell Volume
MCV 85.3
MCV
MCH 29.3
MCH
MCHC 34 .3
MCHC

31-01-202(
https://pwsapp/NHIMS/OPD/Casesheet_InvestigationResultView.aspx?VisitID=356470 ...
· Jm esti!?ation View Page 2 01 z

ROW ROW 16.8

Rae Count RBC 3.51

. 0.0
Nucleated R~ 8:(lOd Cell NRBC Total count

r.Jucleated Rea B ood Cell NRBC Percentage o.o

Mean olatelet volume MPV 8.6
 Department of Radiodiagnosis & Imaging
INHS ASVINI Colaba, Mumbai - 400 005
Tel ••· 2214 3705 / 2214 3500-3705 681
Name:
D 1<- J l 4.
Age I Sex : 3'L yrs I Date: illilw
Rank:
f~T
Relation:
~t Ward: ~

ULTRASONOGRAPHYREPORT
ABDOMEN ,,aol,,JP,Po~ ~ - (...o C - y ~ -
1._Jo L,..7V.

Liver m size in cc axis, in MCL. f:cho.

'\...v~+,-...Su..>-~ h l - ~

No focal Lesion. No IHBR dilatation.

Gall Bladder

CBD / Portal vein / Pancreas : Visualised parts normal.

. pv - I~ :S- ,.........., c.....,: ~ y ~ _j-;--,+.o L · C \.,,o I () v..J..( -.M I I . 2- c..rv-. / ~
Spleen /,;/-.SU'v'I, in size. Nonna! echo. No focal lesion. J-f\,v.:,

Both Kidnevs Right Kidney : II c.....,__, in size. CMD is maintained. Nonnal echo.

No focal lesion/ PCS dilatation / Calculus.

Left Kidney lt , 6 u . - , in size. CMD is maintained. Normal echo.

No focal lesion/ PCS dilatation/ Calculus.

Urinarv Bladder: pc.,.,-h·cJ.) Distended, anechoic contents.

No Ascitis / RPLNE.
p uv, ~ J-...'..,

Comments:

1es
_-:1t
r ~ v,n,
p F,8579 /2 .it> D c.,,.:.,....,, t.. , : , ~ . . I ) ~t " pu~ c-f ~ p .,_J ~ " " ' c,.., ' .,
IMPRESSION : J c..J~
 .
Ll,7 • PP-ASHWINI HOSPITAL, COLABA
Near RC Church, Colaba Mumbai,
Maharashtra ,00005

1/2/2020 6 41 OOPM
CollQC:tod
Name SGT. O.K.JHA 904177S 11212020 o o.,oPM
Rf!colvod
M:alu 3/2/2020 5.48 02PM
Lab No. 276490500 Ago: 32 Ve3ra Gondor: Hoportod
Report Statua Final
Ale Status p RofBy: AMW

Sia, Ref. lnterva!

Test Name Results Unita

Or R :'!>II Oat,_ S.,,gt, Dr Anl Arnrl Dr Himang,ho M,izumd ,r

UD.P~ MO P1th01ogy 1.10 lliOC:hemiatry
a,..r ci, ~ HOD Hemllology & Senior CoMultllnl • Chnlcel Cheml51ty
Or.:..al~Ud lmmunoholNIIOlogy A 8.Dchom.UI GcMliea W:U. • 0, ..al Pfff.:...ts
NRL • Dr LIii Pellll.all9 Lid r4JU. • Or Lal l'elhLllbl Lid

OrN=~
l,!!}~liSlr)
~ ~-Oneal Cher=!.,y &
-
o, PINI C"<>Pt•
!IJ) Labotlto,y MIJdleina
Consul.ant
a.oc..- a.a Gencl::s llRl. • Or Lal Patnu,b1 Ltd
NRL-OrutlFi~W
- - - - - - - - - E n d of r e p o r t - - - - - - - - -

IMPORTANT INSTRUCTIONS

•r~ ~ r ~ per.ail'l to the tpeetmen subm,ned "AH test results are dependent
•~ ~ a•e c,riy a toot lo tacirtate 1n amvang at a diagnosis and ghould be dmtca!ly CQf'l'ela!e,
are ~ oo rei.;.iest o1 Refemng Phys10an within 7 days post repo111ng •Repon de!.'.'1ery
~...161JQ';! r&Qrded "Certa n tests may require further testing at add tlorul cost fur
72 h:>url ~ repotf!!IQ "Tit$! rosults may &how antortaborntory variations "The

"' ~ 'daiJ • cornicming the ll'~t(,) & 0< re1oul1s

related w te I ro~ults
 U7 • PP.ASHWINI HOSPITAL, COLABA
~ RC Church, Colaba Mumbai,
lbharut\trll '00005

Name SGT. D K.JHA 904177S Collected . 112/2020 G:41 00PM

Roc11lvud , 112/2020 t'U3:40PM
lab No. 276490500 Age· 32 Year• Gend0r· Mil• : 3/2/2020 5:48.02PM
t-t•ported
Ale Status p R~f By· AMW Roport 6tatua · flnal

Test Name Results Units Bio. Ref. lnterva.1

metallocompounds and Vitamin A Deficiency of iron, leods to mIcrocytIc hypochrom1c ar,(1m1a. Tne to1.JC
effects of iron are deposition of iron in various organs of the body and hemochromatosi~.
Total Iron B inding capacity (TIBC) is a direct measure of the protein Tram,ferrin which tram.ports uon lrom
the g.,t to storage sites in the bone marrow. In ,ron deficiency anemia, serum iron 1s reduced ar.d Tl3C
mc·eases
Transfemn Saturation occurs in Idiopathic hemochromatosis and Transfusional hemoslderos1s where no
u~sa,u--ateo :ron binding capacity Is available for iron mob1lizat1on. Similar condition is seen In congemtal
ce~.:rency of Transferrin.

ANTI NUCLEAR ANTIBODY/ FACTOR ( ANA/ANF) IFA (HEP-2) ENO POINT TITRE @
' =A

Negative

1:100

Note
1. lmrr:mc;ffucrescence microscopy using human cellular extracts like HEp-2 cells is a sensitive test for
ce~e::ton of serum antibodies that react specifically with various cellular proteins and nucleic acids
2 Test conducted on Serum.
3. Pattems are ieported as per International consensus on ANA Patterns (ICAP).

Comments
An• Nu...'iear ant.body ( flcNA I A..NF) Is a group of autoantibodies directed against constituents of cell n ~
ru:t.td:tg DNA, RttlA &. various nuclear proteins. These autoant1bodles are found with high froquc~, in pa• ~
2h connect.ve tissue di&erders specially SLE. Since positive ANA rosults have boan rtiportoo ,n he.at~,
ma idua1s these reactivitie, aro not by thornselvoa diagnostic but must bt1 corrolatod with otht1~ lJboratZlf')
:"11Ca1f~ngs
 L •7. PP-ASHWINI HOSPITAL, COLABA
Near RC Church, Col1b1 Mumbll,
Maharashtl"I 400005

Collectod 1f2/2020 8 41 OOPM

Name SGT. O.K.JHA 904177S
Rectlvtd 11212020 e 43 <&OPM
Lab No. 276490500 Age: 32 Yura Gender MIio Reported . 3'2/2020 5 -48 02PM

p Report St•tus Final

Ale Status Ref By : A.MW

Test Name Results Units Bio. Ref lnwvat

I1-----------------1-----------------------
'=1.00 I Reactive/ Acute/
I I Resol\ing / Chronic
I I HBV infection
Note
1 Discrepant results may be observed in patients receiving mouse monoclonal
antibodies for d1agnos1s or therapy
2. For hepannized patients. draw specimen pnor to heparin therapy as presence
of tibnn leads to erroneous results

Comments
Anti- 1--iBc Total s the first antibody to appear usually 4-10 weeks after appearance of HBsAg a• -., sa,~
time as dinical i 1ness and persists for years or maybe hretime. It is almost always presen1 cu...:,g chrm'=t
1

...:gv infection. It detects virtually all individuals who have been previously infected with HBV. Oete:::t.:r. of Ar.
i.;Bc Total positi\-e donors reduces incidence of post transmission Hepatitis and poss o ty 0
1
er.---:-·
nfections like HIV due to frequency of dual infections. This antibody may be seen 1n 2% o1 ro..t. ne ckr::lrs
without any other serological marker and with normal liver enzyme levels. This 1nd1cates rec~ =TY Ml--
suxl:mcal r.BV ,r,fect,ons. Anti HBc Total is not protective and cannot be used to dlStingu.s.,i. :..O.....e ~
Chron c mfection.

Uses
• A.s a marker for HBV infection
• f..s a screening test for blood donors

rRON STUDIES, SERUM

(FerroZ;ne)

8.00 ugldl
Iron

Tora! Iron 8.nd ng Capao;ty (TIBC) 220 00 ~,~'dl

fut ral'on

Comments
Iron an rrt I lt min r I I m,mt wht h form lli
 L27. PP-ASHWINI HOSPITAL. COLABA
,-.~ar RC Church, Colaba Mumbai,
Maharashtra 400005

: 1/2/2020 6 41 :00PM
Collected
. 1/2/2020 6:43 :40PM
Name SGT. D.K.JHA 904177S Received
3/2/2020 5:48:02PM
Gender: Male Reported
Lab No. 276490500 Age : 32 Years
Final
Report Status
A/c Status p Ref By : AMW

Bio. Ref. Interval

Units
Test Name Results
t for diagnosing Wilson's disease Serum
copper to tissues. It's quantification 1s used as a screening tes . copper excretion and
, . t d with increased urinary
ceruloplasmin levels are reduced 1n Wilson s disease associa e normal ceruloplasmin
increased hepatic copper content. 15% of patients with
· wI1son •s disease may show
levels. Factors which increase ceruloplasmin synthesis are cytok1nes, pregnancy & eSlrogens.
22 00 - 322.00
FERRITIN, SERU-;., - 80~00 ng/ml
(CUA)
- - ·----------------
Note . Increase ·1n serum ferritin due to inflammatory cond'1t·10ns (Acute phase response) can mask a
diagnostically low result

Comments
Serum ferritin appears to be in equilibrium with tissue ferritin and is a good indicator of storage iron in normal
subjects and in most disorders. In patients with some hepatocellular diseases malignancies and
inflammatory diseases, serum ferritin is a disproportionately high estimate of storage iron because serum
ferritin is an acute phase reactant. In such disorders iron deficiency anemia may exist with a nonnal serum
ferritin concentration. In the presence of inflammation, persons with low serum ferritin are likely to respond to
iron therapy.

Increased Levels
• Iron overload - Hemochromatosis, Thalassemia & Sideroblastic anemia
• Malignant conditions -Acute myeloblastic & _Lyrnphoblastic leukemia, Hodgkin's disease & Breast
carcinoma
• Inflammatory diseases - Pulmonary infections, Osteomyelitis, Chronic UTI, Rheumatoid arthlitis.
SLE, burns
• Acute & Chronic hepatocellular disease

Decreased Levels
Iron deficiency anemia

HEPATITIS B CORE ANTIBODY (Anti- HBc), TOTAL, 0.24 Index <1 .00
SERUM
(ChemiluminesE~t Microparticle lmmu!'oassay)

Interpretation

I RESULT (INDEX) I REMARKS

l----------------- 1-----------------------
I <1. 00 I Non Reactive /
I I Not Detected
I I

t:ltf $2 ■ 1.
 ......._
. . AII . . . NQIPl1'N..CGI.W
-•CIMllh.o...--.

Nam. SOT DK JMA IMHl'I c.,,...., t/l/llNM1 . . .

lab No.

AA:Slalua
l?MlolOO
..
At• uv..... Gender ..... ...,.,...
NtOllvtd ,1112no t;41...,..
~•M~
,,,..
AtlW lll1po,111Mtu•
ftttf ·~

,...........
~ ( A ~ f"E"°"'°mN), TUM°" MAltKll!lt,

----
Nole
Ct."

2 Thrs test ,snot recommended to screen cancers In the general population.

2 Fa se negative/pos,t,ve results are observed ,n patients receiving mouM monodoflill
ant bodies for dlagnos,s or therapy
3 Us~ of AF'P as a tumor marker II not recommended ,n pregnant females.
~ A.FP values regardless of levels 1houfd not bo interpreted •• absolute evidence for ._
prresence or absence of d,1911119 All val1191 ahoulO be correlated with clinical flndtngl and
results of other mvest,gahons

•
Useful for determining prognosis and tnOnf10fing thWepy for Hepatocellular carcinoma ~ of
AFP rs a prognostic mdicator of IUMvaf Elevated AFP and serum bllirubin levels in . _ . .
patients rs assoc:iated with shorter survrva1 time
•
An aid ,n the management of Gem, cell (Non.Sem nomatous) tumors. Measurement of ~P
le\,els m oomblnabon with HCG levels are useful n dassdying and staging Germ cell tumors
• To pt8dic:t tumor recurrence/presence of residual tumor

Inc, l ■ dLewals

• G8rm oel Non-Semtn0matous) tumors

• Awawy ~ r carcinoma (70%)
• T•...._,c■iun\l

.•
•
-----~
Gl■I cw t • 1111 tr.a cancers with or without liver metastas,s
. . . , , hip ■tc CDnditiona fb Acute Vtral Hepatitis, Chronic active hepatrua and ~

·--►~-.,.
34 10

l . . . . . . 47-1 ••llf'I .,..,

11 IINffl Ind • lllo ...
■ ti■ I .... hlltn '11 atr:f§JCHPWI ■ tD ... td1 ...
 INHSAIVINI
l fa
....,
)(} ('lftN'nm

""'91N 0 ..
Wtt, IUJI'
~, ,,on
f\lllllNd~ l) ~kT._._.,_,,Nll•ot

W'1tl1tD 20lQ/ OOII (Ufllftt)

~ £SLD, Melena

re,.,_
Mil I0:9MOA1Ncw»py IIPOU

bOJB@IA8US
Of~~ Gr.ae Ihe: l, Gtide I JC 2 no RCS, no IU9mat•

M fd PHG, no tunes.I vetta

D-l: Normal
D-2: Nom'laf

I • C t - • -, '· • • •

._ilAL1Rra:r4ao..
IIUFl&I PhL "••rca
 . . ...... . .
ECHOCABDIOGRAPHY REPORT
DEPARTMENT OF CARDIOLOGY
INHS AS~INI, COLABA, MUMBAI - 4 OOS oo
Name : D{: ;:)o..... s~f/Wife,'SeA/Daughte,/Metl:ler/Fa t her-ef - - - - - - - - -

Rank : M-. P. No : qr)C,r-r:\.<; Age : .3Q. Yr(0 _ 02 J'?~

-M F Date 02>~ ECHONo· .
I J I
PARAMETER MEASURED DOPPLER MEASUREMENT
Ao Orifice Peak Gradient Mean Gradient
LA Aortic
RVIDd
IVSd • Mitral
LVIDd
LPVWd Tri cuspid
IVSs
LVIDs Pulmonary
LVPWs

Ejection Fraction

left Ventricle (Nor~

5r'~61') %

/ Dilated/Hypertrophied
E/A fl.. )/1

Left Atrium ~
--
rma~ Dilated
RWMA - LA ex/RCA (),_,ii{ WAA/J-
Norma Mild/ Moderate/ Severe.
Right Ventricles Dilated Right Atriumy / Dilated

Mitraf Valve $ /Abnormal · Aortic Valve a Abnormal

Tricuspid Valve ~
c;7~ (d70
~{d/4~
/Abnormal
0
Plum Valve a Abnormal

lAS/NS
<:vu,! /MA-
Ase Aorta IVC: SVC:

Pericardium

CONCLUSION

CARO OlO
 .............
ECHOCARDIOGRAPIIY REPORT :/
DEPARTMENT OF CARDIOLOGY
INHS AStJINI, COLABA, MUMBAI • 400 005

Name :

Rank ·.
-
.[\

-
{!
--- •
.:io.,_
------l.-J.....A,....::::~- -
p No .
• ---Ll~ :.....L-QF-
Age :
~ e
s:ff/Wife/SeA/Daughter/M 9t t:ler/Fat heH1f - - - - - - - - -

Yr - M F Date
(23~ l'?OZZ) ECHO No:;___ _
~

PARAMETER MEASURED DOPPLER MEAStJREMENT

Peak Gradient Mean Gradient
Ao Orifice
LA Aortic
RVIDd
IVSd Mitral
LVIDd
LPVWd Tricuspid
IVSs
LVIDs Pulmonary
LVPWs

Ejection Fraction E/A

left Ventricle __ Dilated/Hypertrophied left Atrium Dilated

RWMA - LA ex/ RCA ~I{ WAMJ-.

~
Norma Mild / Moderate/ Severe.
Right Ventricles Dilated Right Atrium / Dilate

Mitral Valve Aortic Valve e/ Abnormal

Tricuspid Valve Plum Valve A Abnormal

~
IAS/IVS

Ase Aorta IVC: SVC :

Pericardium
CONCLUSION

(S~ ' l
- C
 Department of Radiodiagnosis & Imaging
INHS ASVINJ Colaba, Mumbai - 400 005 20 0 -...
Tel.: 2214 3705 / 2214 3500-3705 r

Name: ~ K -1h"- Age/Sex: ;1. yrs/ fl/\ Date: O?-t'l,.~1.D

Rank : Relaiion : ~L Ward: 1

ULTRASONOGRAPHY 'REPOT{T

c~~ ~ ~~/ ~
A ti...Jj CMAL, 1. ,) f.µti1w.. i.)ui. k

'
~ -t:_ • N u ~ ~ / 11-11\/tb .
~ ; I f .-:l_, ~ ,

Pv .. r3 'Yv\i.,,.,-.. AA- ~ .· -+uyJor ~ c (!J ~f~

tS: ~ ?-I- ~.M., .

sr-v ;. I 3 ·7 ")'\\ .-vv ~~

S,MV 7 12. MW~

~JPRESSJON :
- CONFIDENTIAL

INHS Asvlni
Near RC Church, Colaba, Mumbai
AG NETIC RESONANCE I MAGI NG

DE~::.Ho:,~:,~DIOLOGY AND IMAGING. H

UHID 111111111
Patient N•me : SGT D K JHA 9041 77 5, 22 AU

;P/ GASTROENTROLOGY
Cateuory : Service Person W •rd / OPD AND RESPIRATORY
WARD

Relation : Self N• m e : D K JHA

Rank : SGT PNo : 9041775

Unit : 22AU : 32 Year{s)/MALf

Au e /Gend er

O rdered By
: CAPT ( MNS) SARU CHAUHAN NS23313L Requisition No : 579511
Auth o rized B y
: SURG. CDR HASHIM P I MR072 57N Requisition Date : 04 Feb 2020
Auth o rized O n
: 08 Feb 2020 Accession No : 200204189

Proced ure : Abdomen MRI

Rel e v a nt Clinica l
D e t a ils

Sca n D e t a ils
Acut e on chronic liver failure
Hematemesis & malena

Evaluation of the abdomen was performed on a 1.5 Tesla scanner. Tl Weighted

-
FLASH 3D sequences were obtained pre and post contrast. T2Weighted axial and
coronal, chemical sh ift imaging was done .

Findin gs/ Observations Gross ascitis seen- perihepatic, perisplenic, interbowel & pelvic.

Spleen measures 15 cm in CC axis .

Portal vein measures 12 mm at origin.

Liver has surface nodularity . It is normal in size, signal intensity .Caudate lobe
h y pertrophy seen . There are no focal areas of altered signal intensit y on any
sequ ence .

Gall bl adder is normal and there is no intrahepatic or extrahepatic biliary ducta\

dilatati on .

The h e p atic aretrial system shows normal appearances .

The aorta a n d its major bra nches are normal.

There are no a bn o r ma l e nla rg ed lymph nod es noted .

Both kidneys & adrenal glands are nor m al.

ressfon/Conclusion MRI scan of the liver and abdomen reveals:

1. Gross ascitis.
2. Splenomegaly. • \er.vb\.~,~~
1
- "-- '--
.:> • P--'\ U.'6'~ .s, a <::l,r,o~)!(!. AS \-{'r.; p \
~ ~
c;\.V
QS-0:-~
ppfNI JJMS/Radio1ogy/Report.aspx?Report Name- ResultEntry·Resu\tEntn)
· ·
 ..Putmo.nary Func.t1on Test Resu lts

Dept of Rcip,ratory Medicine

ms
INHSASVl'-11

Visit date 04-02-2020

Pat tod Age 34

::,urnan>E: ~~ A Gender Male
l'.arne CK Height , cm 178
Date of b 1 h _,2 o• 1986 Weight, kg 82
Ethnic group North ind1an BMI 25 88
Smoke No smo1<er Paclt:-Year
Patient group

....
Interpretation iii ;.-
FVC FEV1 FEV1%
6 ~ ~

Normal Spirometry

B e s t v a lues from all loops

- --
rr Chg
l r I
'
FVC L. J ')2 • ~3 4 29 95 -0 39
FEV1 L 2 2 4 6~ 3 57 95 -0.37
FEV1°o 69 J 92 9 83 20 103 0 29
/ Predicted - ERS (ECCSJ . ( ru-1:;-=.-
PEF Us - 6.j 1• 6 ' 9 62 100 000
4

PRE Tria l date 04-02-2020 13 :22: 55

- -~
1oPrf:.d z. r core PRf 2 ;.,-.;~ -, POST#" P re-:! ~

FVC L 3 52 5.53 4 53 4.29 95 -0.39 3.94 3.40

EVi L 2 92 4 60 3.76 3 57 95 -0 .37 3 23 2.84
V1/F VC 68 3 92 9 81 1 83.2 103 0.29 82.0 83 5
F 7 63 1161 9 .62 9.62 100 0 00 5.06 6 59
34 41 121 54 '39
~ 98 6 40 4 .69 3 66 78 -0 99 3 32 303
6 00 5.0 0 83 3 95 344
; ':,2 5 53 4 53 4 .57 101 0 .07 4 50 ~ 5'2
69 3 92 9 81 .1

clu$;ion 1 M~rli~al r:Pnort

 DIAGNOSTIC REPORT

D1agnost1cs

CLIENT CODE : (000000658

11111~-l\\~~~~:m.
~~~~~R:U:
.'!1111 . . · CAP ~
v%f'I ~J/1,,.i
ACCREDITED I
..
, , ,,,.. ..,.
CLIENT'S NAME AND ADDRESS . Cert No. MC-2010
!NHS ASVINI HOSPITAL •
COLABA, COLABA NEAVY NAGAR SRL LIMITED NDUSTRIAL
COLABA ' ' PRIME SQUARE BUI LDJNG,PLOT NO 1,GAIWADI I
MUMBAI, 4 00005 ESTATE,S V ROAD,GOREGAON (W)
MAHARASHTRA INDIA Mumbai, 400062
9820259409 MAHARASHTRA, JNDIA
Tel . 1-800 222 -000, 022 - 67801212
CI N - U74899PB 199SPLC045956
(mall connccl@srlln

PATIENT NAME : D K JHA PATIENT JD :

ACCESSION NO : 0002TB011277 32 Years

AGE . SEX . Male DATC or BJRrll :

DRAWN : 05/02/2020 00 :00 RECEIVED : 05/02/2020 1 9 : 53 REPORTED 06/02/2020 13: 29

REFERRING DOCTOR : CLIENT PATIErlT ID :

Test Report Status Results Biological Reference Interval Units

EIA - INFECTIOUS SECTION

CYJOMEGALQYIRUS IGM, SERUM - . . _____ ,

CYTOMEGALOVIRUS !GM 7.02 < 18.0 Negative U/ml

18.0 - 22.0 Equivocal
> or = 22 .0 Positive
METHOO : CHEMILUMINESCENCE IMMUNOASSAY

Interpretation(s)
CYTOMEGALOVIRUS !GM, SERUM -
CYTOMEGAlOVIRUS !GM, SERUM

Cytomegalovrrus (CMV) rs a member of the Herpesvirldae family and Is classified as Human herpesvrrus Type S.CMV causes a number of protean disease synoror.,es m mfants
as well as adults. lnfect,on ,s common and reaches most or the population, whereas associated disease Is relat,vely rare. CMV rs a recognized cause of monoeuClec;s s a-~
hepat,os amongst normal Immunocompetent rndivlduals .But ,tis among the immunosuppressed (Immature neonates, organ transplant reop,ents. AIDS pat>ents) t.-:at CMV
causes most s1gnrficant disease, manifesting as hepatitis, retinitis, pneumonitis, encephal1t1s, colitis etc.

The nsk of an infected pregnant woman transmrttrng CMV to the foetus is highest ,n the 3rd trimester and during the brrth process (Perinatal infeet,on).
Jntrautenne/Congenrtal CMV infections, though less frequently seen than perinatal infections, are responsible for causing severe CMV diseases that may be fatal. Such
rntrautenne/congenrtal CMV ,nrect,ons are usually seen in infants born to mothers suffering from a primary infection during pregnancy

Test Utility:
CMV speofic lgM develops a few weeks after acute infection followed by development of lgG about a week later. lgM levels usually increase for some wtt..s an<! then
decrease slowly rn four to srx months. Occas10Aally, lgM may circulate for years.

A pos,t,ve CHV lgM result may not always indicate a pnmary acute Infection, as lgM has a tendency to persist, even at high levels, after pnmary inlect,on. false-l)<ls t,ve \;M
results may ocwr due to rheumatoid factor and antinuclear antibodies. Hence, lgG avidity testing Is recommended to d1Herent1ate between pnmary 1nlectt0n, \gM ~ s \ e ~
and reactJvat,on.

Avidity ,s defined as the functional brndrng strength of antibodies to multiple binding sites (epltopes) on the antigen . The test 1s based on the pnnctl)le tl'\at ant bac1~s IOl'meG
rn response to promary infection have relatively low avidity to the corresponding antigen With time, a broader antibody response develops "41th ant1t)od1t'> bemg tanned to
more ep1topes on the ant,gen and with a corresponding Increase In the antibody antigen avidity . Therefore, when a secondary ant,boJy response occurs wtth re1nl~n
stimulates donal expansion of memory B cells to a much wider spectrum or epltopes, producing antibodies of conslderably greater avidity.

A pos,t1ve IgM accompanied by low-av1d1ty JgG Is suggestive or a primary Inrect1on, whereas a high avidity lgG Ind1cates either lgM persistence or reat\"at,on ._'°"'av.
,ndex may also be seen In a proportion of Infected persons for months Hence rt Is adv,sed to perform lgM testlnq InItI,1lly to l'lllnt to the neN for ll)G G'IIC ty \o a.
m1smterpretat,on of results.

Um1ta1,ons:
Samples which ar~ s1ron9ly pos1t111e for the prl"~enti• uf anti V,1rln·ll,1 70~1, r (VIV) Mid (lJ~l rln O,,rr lqM ,111tIlto,lles till\ qMi l,11,e posih~e results ~se
compllcat,ons of SProlo91c d1;,9nos1s of uin9l'n1tal lnfi•rllon, vIru•, 1~01,111011rro1111111m 111 thr llr ,l wr1·I. ot 1111'! rr111nm~ lh" b< ,t w11y to d111g~ 111\r!lule
A~ence c,f CMV si,euf1r JgM does not f )(((udt thr pc,<•ll11llty c,f (MV "''"' 11011 11110111 l tl 10"/u ul 1111,111\ • lll~Y 1011 to (\t"velc,p (Ml/ lg!o\ llflhbody ~Mtt
1nfect1on with ow.
• .tend Of Rrpo,t• •
Plea.e visit www.srlworld.c.om for ,elnlrd TC"sl Tnlo1ma\lon 101 this aucsslon

Dr. Eku, Patll,MD

(Rep No MMC2008/04/1l42)
Hmoblologlst
 I I IIPI II I 1'111111

I 11111 1111 I
111.,1111111 11\1

\Ii \I 1 'II 'II 11 If

1\111 \I
I I 111 1 d 111\111
Iii th I \ 1•11 11 I II Ii 'II II 11
1
1 I\h 11\ \l 1111,
I \, I Iii I
I \1 1
'"
'\i ll

I 111111\ II Iii\'' I 1\111 II II

·1~1111111 Nh•tl,tl
1•11 II
\'' ,, 111 \ 1111111111
i"' 11 \ r1 1111111 lq
Iii I II I
ll l I 11,11 11111111\il I
\, I 11 1 1111111 11 \ I
I I \111,11 11111111\d I
I 1\11 \ 11 lllti ill I
I II I11 111111111 1

I ,~I l~1th11I
11111 II I
\•II' 111 I 1111111 lq
1,1, I 1, 1(j
1111111111
Iii \I

It JI 111 '" 111111 ..11

111111, 11I
Iii "I
111111"1 I
,,, 1,
'II 111111,,1 I
,111 11 l111111,II
II I\ I I II 1111 ·i11
I' I 'I' I ,11
,,,, 111111 Iii\ 1111 "'
1111111111
A, J\ II I 1, 11
11111111'1
I I\ II fl
1:1 Ii I
i'11 I It, 11,j 11 1111111111
~
1
.1 I 11
Ii/
Ill, 11 I 111dl
•1111,1,1 'I' I I 111111111 I

111111,1111141 N1 ii
1.. w lllql1 l,,w Iliqlt
1·11 I 111 / 1111 { 111 I I 'Iii
jlt• Ii 11111 \
1
111 I/ II
1
II \111111 II I \I Ill
liil '11 1, 11
111 I II II I 11111 I II
I I II 111 II r
I
II I I I

II
"
 CONFIDENTIAL

JNHS Asvinl
Near RC Church, Colaba, Mumbai
NG COMPUTED TOMOGRAPHY
OEPARTMENT OF R.ADlOLOGV AND lMAGl •

UH10 : ASVl.00003-40151

Patient Name : SGT DK lHA 90417'S, 22 AU

i111GAST fWWl P.OLOG't'

Category : Sl!NICC l'ct"$0n
Wt1d/OPD AtlO .R[!iPIAATORY
WARO

Name : 0 Y. JHA
Relation : Self

Rank PNo : 90417'7li

: SGT

Unit Age/Gender : 31 Yetr(~)/MAU!

: 2.2 AU

Or-ctered By • SURG. LT ABHISHEK CHOUDHARY achoud0l Requisition No : 58181"/

Authorbed By • SURG. LT COR NlHARIKA GUPTA 76008w Roqulsltlon Date : 06 Fe!> 2020

Authorfz.ed On : OS Fet> 2020 Accession No : 200206030

Procedure : Chest CT

Relevant Clinical Decompensated liver disease

Details For pre-transplant wor1< up

Scan Details 5 mm sections through chest an a cranlo-caudal direction in spiral mode were
obtained from the level of root of the neck till the adrenals and images
reconstructed in both lung and soft tissue windows.

Findings/ Observations • Small loculated pleural effusion noted along right lateral chest wall adJace~: to
lateral basal segment of Rl.l for ~3 x 0.8 cm in max dimensions .
• Subsegmental patchy consolidation is seen involving the antenor segment c1 tt--.e
Rl.l. Rest of the lung fields are clear .
• Few discrete lymph nodes without any obvious necrosis or calc1ficaticn n~t~ .,.
paratracheal, pretracheal & precarinal stations with largest measunng S m-n
MSAO at right precarinal station.
• The trachea and main bronchi are central and normal.
• The heart and mediastinal structures including the oesophagus are norm.a
• The i11sualised spine appears normal.
• No left pleural effusion seen.

In the FOV,
Hypodense collection is noted In perihepatic & pensplenic location & ngh!
subdia phragmatlc location.
Swfac.e nodularlty of liver noted.

I ion/Conclusion HRCT chelt revealr;:

mpress 1• Small looulated pleural crruslon olong nghl leternl ch~t wo
2. Sub!iegmcntal patchy con"olldntion Involving the ftntenor segmc t

~IIPvt'i 1l 1011 1 R P irt rx R port~ 1

 INHS Asvini
Near RC Church, Colaba, Mumbai
SIL OIL Report

UHIO Category : Service Personal

.\S\ • .0000340151

: 202.0J0l/2170 Ward : GASTROENTROLOGY AND

Date of Admission : 31/01/2020
RESPIRATORY WARD
Patient Name
Relation : Self

Name
: 0 K JHA. Rank Unit : 22 AU
: SGT

Age
: 32 Gender : 904177S
: MALE P.No

: ACUTE HEPATIC FAILURE (INV)

Remo\1ed from Dtl at 08 Feb 2020 9:49:19AM

Patient Condition : Stable

NOK Informed

NOK Address : JHA, S, SMQ-144/6 AF STATION NALIYA, JHAKHAR, Samastipur, Bihar, INDIA, 9140936807,
997839242

~e n erated By: MS17419F on 08 Feb 2020 9:49

V\Shvv~CS
f1.":1i A';IJ,,._
\\ll l'\~► RESIDEN i
\Nr\) A~'v\N\
 CONFIDENTIAL A.F.M.S.F - 9
SPECIAL INVESTIGATION FORM
INHS ASVINI Colaba, Mumbai- 400 005
PART-1
WARD - f\V.J..- I[.
NAME: RANK: i!, P. NO.: ~co Lr, ~s
UNIT: L."2-- A--u AGE/SEX: Q'.l.-'171'1\i NATURE OF SPECIMEN: Lu .VO~
EXAMINATION REQUIRED:

BRIEF CLINICAL NOTES : ~ ~g,,5

VISHWANAt-fl-
DATE: 0 f\ -~IGN OF MOI/C
r
- p We_ N~e c hv.,_,-..-:i f:/ b ~--wl ~ 1~✓ fJ- 12, J,,(.. •

/I{ 11/vi/VJ":/)'IVVf ; ~ " '-"" '¼fL--d- Hsi,, 1;1N.- ~../.

Pff•·-vo: nv { ,vq.. hvp p rvv IL) _
- ~'\q~ -t/4A,vyu, PVY-i • A..R <!,~'7 )-o
Me,.,,~ v d:t✓v~ f2-1,- M~vv,'/4 ~ ~ t -
i~.